header

Evaluation of the osteomodulator and cardiovascular protective effect of in combination with risedronate, raloxifene and strontium ranelate in an osteoporotic rat model / (Record no. 71729)

MARC details
000 -LEADER
fixed length control field 03568cam a2200349 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field EG-GiCUC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250223032252.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190502s2018 ua h f m 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-GiCUC
Language of cataloging eng
Transcribing agency EG-GiCUC
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
049 ## - LOCAL HOLDINGS (OCLC)
Holding library Deposite
097 ## - Thesis Degree
Thesis Level Ph.D
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Cai01.11.29.Ph.D.2018.Am.E
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Amira karam Mahmoud
245 10 - TITLE STATEMENT
Title Evaluation of the osteomodulator and cardiovascular protective effect of in combination with risedronate, raloxifene and strontium ranelate in an osteoporotic rat model /
Statement of responsibility, etc. Amira karam Mahmoud ; Supervised Soheir Abou Elazm Diab , Ghada Mohamed Abdelzaher Hashem , Mira Farouk Youssef
246 15 - VARYING FORM OF TITLE
Title proper/short title تقييم التأثير المحور لأستجابة خلايا العظام و الواقى للقلب والأوعيه الدمويه للسيمفاستاتين منفردا و بالأضافه لأى من ريزيدرونات: رالوكسيفين و سترانشيوم رانيلات على نموذج هشاشة العظام المستحدث فى الجرذان البيضاء
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Cairo :
Name of publisher, distributor, etc. Amira karam Mahmoud ,
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 194 P. :
Other physical details facsimiles ;
Dimensions 25cm
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pharmacology
520 ## - SUMMARY, ETC.
Summary, etc. Background: Osteoporosis is one of the deleterious side effects of long-term glucocorticoid therapy. The side-effects of the currently available osteoporotic therapies and their ability to increase bone mass is relatively small not more than 2% per year so, there is a need for novel drug therapies for the treatment of osteoporosis. Evidence that osteoporosis and cardiovascular diseases are positively correlated. Therefore, the attention has driven toward the importance of possible synergism that might occur from combination of anti resorpative medications with simvastatin. Aim of the work: Assess the osteomodulatory and cardio vascular protective effect of Simvastatin, residronate, strontium ranelate and raloxifene separately and their combination with simvastatin in rat model of glucocorticoid induced osteoporosis. Methodology: A 72 Mature healthy albino rats of both sex are randomly allocated into 9 main groups and received drugs for 6weeks by oral gavage. G1: Normal control group,G2:osteoprotic treated group received prednisolone (pred) at 30 mg/kg per 2 days ,G3:Simvastatin(Sim)- treated group received simvastatin at10mg/kg/day,G4:Residronate (Residr)- treated group received residronate at 1mg/kg/day), G5: Strontium (SR)-treated group received strontium at 600mg/kg/day,G6:raloxifene (RAL)-treated group, received raloxifene at 1.25mg/kg/day, G7:SIM+Residr-treated group,G8:Sim +SR treated group and G9:Sim +RAL treated group. At the end of 6 weeks ,all studied groups were assessed pharmacologically by measurement of mean arterial blood pressure (MAP), ECG and echocardiography, biochemically, by measurement of serum Ca, P, osteocalcin(OCN), bone specific alkaline phosphatase (BSAP),ALT and AST. Histologically by assessment of bone cortical thickness, histopathological scoring and bone mineral density by DEXA scan was also recorded
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Issued also as CD
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Antiresorpative medication
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Glucocorticoids
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Simvastatin
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Ghada Mohamed Abdelzaher Hashem ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Mira Farouk Youssef ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Soheir Abou Elazm Diab ,
Relator term
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a>
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Nazla
Reviser Revisor
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Samia
Reviser Cataloger
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
Holdings
Source of classification or shelving scheme Not for loan Home library Current library Date acquired Full call number Barcode Date last seen Koha item type Copy number
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة قاعة الرسائل الجامعية - الدور الاول 11.02.2024 Cai01.11.29.Ph.D.2018.Am.E 01010110077826000 22.09.2023 Thesis  
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة مخـــزن الرســائل الجـــامعية - البدروم 11.02.2024 Cai01.11.29.Ph.D.2018.Am.E 01020110077826000 22.09.2023 CD - Rom 77826.CD